KRAS (but not BRAF) mutations in ovarian serous borderline tumor are associated with recurrent low-grade serous carcinoma

BRAF and KRAS mutations in ovarian serous borderline tumors (OSBTs) and ovarian low-grade serous carcinomas (LGSCs) have been previously described. However, whether those OSBTs would progress to LGSCs or those LGSCs were developed from OSBT precursors in previous studies is unknown. Therefore, we as...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Tsang, Yvonne T., Deavers, Michael T., Sun, Charlotte C., Kwan, Suet-Yan, Kuo, Eric, Malpica, Anais, Mok, Samuel C., Gershenson, David M., Wong, Kwong-Kwok
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4095747/
https://ncbi.nlm.nih.gov/pubmed/24549645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/path.4252
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items